NASDAQ:NUWE - Nuwellis Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $7.50
  • Forecasted Upside: 1,173.56 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$0.59
▼ -0.02 (-3.28%)

This chart shows the closing price for NUWE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nuwellis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NUWE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NUWE

Analyst Price Target is $7.50
▲ +1,173.56% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Nuwellis in the last 3 months. The average price target is $7.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 1,173.56% upside from the last price of $0.59.

This chart shows the closing price for NUWE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Nuwellis.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/4/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/1/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2021Maxim GroupLower Price TargetPositive ➝ Buy$12.00 ➝ $6.00High
9/7/2021Lake Street CapitalInitiated CoverageBuy$9.00Low
(Data available from 7/1/2017 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/3/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/2/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/1/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
3/3/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/2/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/1/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/1/2022

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Nuwellis logo
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $0.59
Low: $0.57
High: $0.61

50 Day Range

MA: $0.64
Low: $0.48
High: $0.88

52 Week Range

Now: $0.59
Low: $0.47
High: $5.30

Volume

97,103 shs

Average Volume

125,011 shs

Market Capitalization

$6.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of Nuwellis?

The following sell-side analysts have issued stock ratings on Nuwellis in the last twelve months: Lake Street Capital, and Maxim Group.
View the latest analyst ratings for NUWE.

What is the current price target for Nuwellis?

0 Wall Street analysts have set twelve-month price targets for Nuwellis in the last year. Their average twelve-month price target is $7.50, suggesting a possible upside of 1,173.6%.
View the latest price targets for NUWE.

What is the current consensus analyst rating for Nuwellis?

Nuwellis currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NUWE will outperform the market and that investors should add to their positions of Nuwellis.
View the latest ratings for NUWE.

How do I contact Nuwellis' investor relations team?

Nuwellis' physical mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company's listed phone number is (952) 345-4200 and its investor relations email address is [email protected] The official website for Nuwellis is www.nuwellis.com. Learn More about contacing Nuwellis investor relations.